MMJ Recs

APRIL 15, 2022

The following conditions qualify for a Missouri MMJ card: Alzheimer’s disease Autism Cancer Crohn’s disease Chronic pain Epilepsy Glaucoma Hepatitis C HIV/AIDS Huntington’s disease IBS Intractable migraines Lou Gehrig’s disease Multiple sclerosis Opioid substitution Parkinson’s disease. What is a MO patient drive? Keep reading!

Patients 52

Patients Chronic Pain Conditions Dispensary 52

MMJ Recs

MAY 5, 2022

In some cases, this can be done through a Louisiana patient drive. Read on to learn all you need to know about MMJ certification and patient drives in Louisiana. Image by João Francisco on Unsplash : How do you set up an MMJ patient drive in Louisiana? What is a Louisiana patient drive?

Patients 52

Patients Dispensary Conditions Access 52

Illinois News Joint

JANUARY 9, 2025

The Illinois Department of Public Health (IDPH), after confirming votes from the Medical Cannabis Advisory Board (MCAB), officially added four new conditions to the list of qualifying debilitating condition for Illinois patients in the Compassionate Use of Medical Cannabis Program. To find cannabis-friendly events in Illinois, visit here.

Conditions 105

Conditions Treatment Chronic Pain Epilepsy 105

Cannabis Law Report

JULY 26, 2021

About half to two-thirds of the cases get much better during adolescence[1]; however, adults will generally be more severe patients[2]. The patients will be randomized in 1:1 ratio to receive either SCI-110 or SCI-110 matched placebo. About SciSparc (OTCQB: SPRCY): SciSparc Ltd. Investor Contact: IR@scisparc.com. Tel: +972-3-6167055.

Research and Development 105

Research and Development Supply Chain Pharmaceutical Treatment 105

MMJ Recs

MARCH 25, 2022

Image by msqrd2 on Pixabay : Looking for more information on patient drives in New York? The application process for a New York MMJ card typically involves the following steps: First, register with MMJRecs and create a patient login, providing some basic information and answering a short and simple questionnaire.

Patients 52

Patients Conditions Chronic Pain Dispensary 52

CannaTech

APRIL 1, 2020

In practical terms, we studied how pharmaceuticals interact, how to accurately measure and dispense medications, advise patients on effective protocols and adverse events, what to do and not to do when using specific medications. Over 60,000 patients in Israel receive medical cannabis through pharmacies and distributors.

Supply Chain 98

Supply Chain Chronic Pain Pharmaceutical Patients 98

Cannabis Law Report

DECEMBER 3, 2021

An analysis from continuous EEG recordings in 17 patients enrolled in the Phase 2 refractory status epilepticus (RSE) study demonstrated a substantial increase in the alpha/delta ratio immediately after the start of IV ganaxolone in 75% of patients. in patients continuing ganaxolone (n=38) and 33.3%

Epilepsy 40

Epilepsy Pharmaceutical Data Clinical Trials 40

SpeedWeed

SEPTEMBER 15, 2021

To address the issue, the Buds ‘n’ Bras campaign will include breast screening events held at its dispensaries in conjunction with Check for a Lump. Patients can call (480) 967-3767 to pre-register for a screening. The company will also sponsor a booth at the event where it will collect new and gently used bras for the nonprofit group.

Dispensary 84

Dispensary Collective Events Epilepsy 84

The Cannigma

MAY 19, 2021

Japan does not have a medical cannabis program and does not allow the use of cannabis for patients seeking to treat a medical condition. In 2019, Japan approved clinical trials for Epidiolox — a cannabis derived medicine used to treat severe forms of childhood epilepsy such as Dravet and Lennox-Gastaut syndromes. Shutterstock).

Law 137

Law Legalization Clinical Trials CBD 137

Cannabis Law Report

AUGUST 17, 2021

reduction in 28-day seizure frequency relative to baseline in tuberous sclerosis complex (TSC) patients (n=23). reduction was observed in focal seizures (n=19), the most common seizure type in TSC patients. Phase 3 planning for TrustTSC trial ongoing with first patient expected to be enrolled in Q4 2021. RADNOR, Pa.–(BUSINESS

Pharmaceutical 76

Pharmaceutical Clinical Trials Treatment Patients 76

Project CBD

FEBRUARY 28, 2023

5 In June 2018, the FDA approved Epidiolex® (GW Pharmaceuticals; Cambridge, UK), the first FDA-approved pharmaceutical drug to contain a “purified drug substance [CBD] derived from marijuana,” for the treatment of seizures associated with two rare epilepsy disorders. Epilepsy Behav. US Food & Drug Administration website.

CBD 144

CBD Seed-To-Sale Food Access 144

CannaTech

JUNE 30, 2019

Changes to Israeli medical cannabis regulation by the Ministry of Health’s Medical Cannabis Association, locally known as Yakar, have left vulnerable patients with reduced access and increasing cots. Although changes were intended to reduce barriers to patient access, this has not been the case. Severe epilepsy in minors.

Patients 40

Patients Oil Epilepsy Strains 40

MMJ Recs

OCTOBER 2, 2023

California has been a trailblazer in the realm of medical marijuana, offering patients access to a variety of treatment options. Patients must first schedule an appointment with a licensed medical professional who can evaluate their medical history and condition. In 1996, the state became the first in the U.S.

Dispensary 52

Dispensary Patients Environment Conditions 52

Cannabis Law Report

AUGUST 2, 2021

” A study conducted by The G4 Alliance reports 300 million surgical procedures are performed annually, with an estimated 60 to 70% of patients experiencing moderate to severe pain just after 24 hours of surgery. The global postoperative pain management market is expected to account for $45 billion by 2026. ” About The Study.

Research and Development 105

Research and Development Clinical Trials Treatment Pharmaceutical 105

MMJ Recs

MARCH 2, 2024

In Ohio, accessing medical marijuana involves more than just obtaining a prescription; it requires navigating a complex landscape of dispensaries, regulations, and patient expectations. This guide aims to demystify the process, offering practical advice and insights to help patients make informed decisions.

Dispensary 52

Dispensary Patients Marijuana Education 52

Cannabis Law Report

SEPTEMBER 20, 2021

Nanomerics”) to use Nanomeric’s molecular envelope platform technology (MET) for the nasal delivery of a cannabidiol (CBD) for the management of epilepsy in adults and children. The Company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise.

Epilepsy 40

Epilepsy Research and Development Clinical Trials Chronic Pain 40

Cannabis Law Report

SEPTEMBER 24, 2019

T he EU has approved for the first time the use of a medicinal cannabis product aimed at patients with two rare, but severe, forms of childhood epilepsy. The medication, developed by GW Pharmaceuticals, will be used in combination with another epilepsy medication called clobazam. What about other medical cannabis products?

Pharmaceutical 55

Pharmaceutical Epilepsy Research and Development Medicine 55

TheAnswerPage

MARCH 11, 2022

In the clinical trials evaluating a purified CBD product (Epidiolex) in epilepsy patients, side effects including sedation, decreased appetite, diarrhea, sleep disturbance, infections, pneumonia, viral infections and weight loss were reported. ” Kirkland AE, Fadus MC et al. ” Kirkland AE, Fadus MC et al. Psych Resear.

Clinical Trials 40

Clinical Trials Epilepsy Events Sleep 40

NewsMunchies

MAY 8, 2023

In 2018, I was a Presenter at a Hillsborough County Bar Association event for a group of judges after Florida passed its limited medical marijuana bill. Florida’s medical marijuana law, passed in 2016, allows a qualified physician to authorize medical marijuana for patients for a variety of physical and mental conditions.

Law 81

Law Marijuana Conditions Epilepsy 81

LifeCannMD

JANUARY 2, 2024

Here’s a breakdown of how cannabis might help those with Florida qualifying conditions : Florida Cancer Patients : Patients say that it benefits them in several ways: by quelling nausea, suppressing vomiting resulting from chemotherapy, increasing appetite, alleviating pain, and soothing anxiety.

Conditions 52

Conditions Nerve Pain Marijuana Epilepsy 52

Healer

DECEMBER 17, 2021

Drug interactions reported in the scientific literature most often occur at very high doses used in clinical trials of epilepsy and other conditions. Patients using warfarin need to have their blood INR level tested after adding THC-containing cannabis to their regimen. topiramate. rufinamide. zonisamide. eslicarbazepine.

CBD 98

CBD THC Conditions Medicine 98

SpeedWeed

APRIL 2, 2021

The legacy of Charlotte Figi, the young Colorado girl whose struggle with epilepsy made CBD known worldwide, will be remembered next week with a benefit concert taking place in her honor. She had a rare form of epilepsy known as Dravet syndrome that caused dozens or even hundreds of seizures per day. She was the catalyst.

Events 52

Events Epilepsy Cannabinoids Treatment 52

Cannabis Law Report

DECEMBER 7, 2021

While cannabidiol was associated with a reduction in reported seizure events (RR?=?0.59, A qualitative assessment suggests that medical cannabinoids might be associated with adverse mental events. Adverse mental events were reported as well, however, more research should be performed to assess well this outcome. 1.69, 95% CI [1.20–2.36])

Safety 52

Safety Cannabinoids Events Data 52

The Cannigma

JANUARY 31, 2021

He said the organization also encourages members to take part in charity events (like 10k and 5k runs) that raise money and awareness for diseases that cannabis can potentially help treat, such as multiple sclerosis , cancer , and epilepsy. Cannabis simply reminds me to slow it down and stay patient.”.

THC 145

THC Cannabis Environment CBD 145

Cannabis Law Report

OCTOBER 1, 2021

This year, the UK hosts the event in Glasgow, from the 1st to the 12th of November 2021. As stakeholders assemble for the summit, one group is aiming to highlight the overlooked environmental credentials of hemp by hosting a fringe event near the climate summit, at St Luke’s in Glasgow’s East End. What is not to love here?”.

Hemp 52

Hemp Epilepsy Events Conditions 52

MMJ Recs

JUNE 23, 2024

Medicinal cannabis laws across the United States have been evolving over the years with many states creating a medicinal marijuana program for qualified patients. At the heart of it, it becomes about patients who have one (or many) of the qualifying conditions.

Conditions 52

Conditions Marijuana Patients Chronic Pain 52

The Cannigma

APRIL 12, 2023

Medical cannabis in Chile Chile legalized medical cannabis in 2015, allowing patients to access cannabis-based medicines with a prescription from a doctor. Patients can purchase cannabis-based medicines from authorized pharmacies, which are regulated by the Chilean Institute of Public Health.

Law 52

Law Decriminalization Recreational Epilepsy 52

Cannabis Law Report

JUNE 9, 2022

The North Carolina Compassionate Care Act would allow physicians to issue a written certification for medical cannabis for patients with 15 listed medical conditions, including cancer, epilepsy, HIV, AIDS, Parkinson’s disease, and multiple sclerosis. This includes proof of military service in an active combat zone.

Patients 52

Patients Consumption Conditions Epilepsy 52

Veriheal

FEBRUARY 28, 2021

The last day of February, the 28th, or the 29th during a leap year is World Rare Disease Day and this day has been designated to help bring awareness to rare diseases as well as the impact they have on patients and their lives. This year, COVID-19 has dramatically impacted the way events are hosted.

Chronic Pain 52

Chronic Pain Events Therapy Treatment 52

Sensi Seeds

JANUARY 7, 2019

As a long-time cannabis activist, entrepreneur and educator in a career spanning 40 years, today DeAngelo is the CEO of Harborside Health Center in Oakland, California, and a regular speaker at international industry events. Joshua Kaplan.

Education 94

Education Dispensary Media Cannabis 94

CannaTech

FEBRUARY 3, 2020

CannaTech is an international event experience that unites cannabis professionals with breakout industry leaders for an unparalleled opportunity to learn, connect and define what’s next for the global cannabis industry. CBD-derived epilepsy drug Epidiolex is currently available in Swiss pharmacies as a prescription drug.

Events 52

Events Hemp CBD Medicine 52

Cannabis Law Report

MARCH 2, 2020

The UK government has eased import restrictions on medicinal cannabis, but has admitted it needs to do much more to improve access for patients. Licensed wholesalers will be able to import larger quantities of cannabis-based products, and hold supplies for future use by patients with prescriptions, according to a government release.

Medicine 45

Medicine Research and Development Clinical Trials Patients 45

Cannabis Law Report

AUGUST 24, 2021

Thus, there is a great need to develop new and effective therapeutics for treating patients. The Company’s second drug platform, Supera-CBD, is being developed to treat chronic pain, addiction and epilepsy. In particular, IPF has an insidious, relentless and chronic course, with a median survival of two to five years. 646) 421-9523.

Pharmaceutical 75

Pharmaceutical Clinical Trials Chronic Pain CBD 75

MMJ Recs

DECEMBER 20, 2023

The establishment of medical marijuana dispensaries in Virginia represents a progressive approach to healthcare, offering patients alternative treatment options for various medical conditions. Patients diagnosed with specific medical conditions are eligible to participate in the state’s medical cannabis program.

Dispensary 52

Dispensary Marijuana Strains Patients 52

SpeedWeed

MAY 5, 2021

Last week was eventful for cannabis reform in Texas, as the House of Representatives approved three legislative proposals, which would expand the state’s medical cannabis program, reduce penalties for concentrates and decriminalize possession. “There’s an incredibly restrictive cap on THC,” Fazio said.

Programs 52

Programs Chronic Pain Concentrates THC 52

SpeedWeed

MAY 4, 2021

Last week was eventful for cannabis reform in Texas, as the House of Representatives approved three legislative proposals, which would expand the state’s medical cannabis program, reduce penalties for concentrates and decriminalize possession. “There’s an incredibly restrictive cap on THC,” Fazio said.

Programs 52

Programs Chronic Pain Concentrates THC 52

Puff Puff Post

MARCH 2, 2020

(Source: New Frontier Data). · Domestic quotas represent a further milestone in the Company’s stated timeline to bring the first medical cannabis products to market in Colombia, targeting patients with two priority conditions; chronic pain and nausea associated with chemotherapy. United States Disclaimer.

Extraction 52

Extraction THC Chronic Pain Cultivation 52